Epidermolysis Bullosa Simplex in Children with De Novo Pathogenic Variants Disturbing KRT14
March 2024
in “
International journal of molecular sciences
”
Studysummary In this study, researchers identified three pathogenic de novo genetic variants contributing to epidermolysis bullosa simplex in young children, highlighting the complexity of genetic influences and underscoring the need for early genetic screening for accurate diagnosis and effective management.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
This study investigates Epidermolysis Bullosa Simplex (EBS) in children with de novo pathogenic variants affecting the KRT14 gene, highlighting three cases with different mutations (Met119Thr, Met1Val, Arg125His) and their clinical manifestations, such as skin blisters, hyperkeratosis, and mottled pigmentation. The research underscores the genetic complexity and clinical variability of EBS, emphasizing the importance of early genetic screening for accurate diagnosis and management. Immunohistochemistry and immunocytochemistry analyses revealed disruptions in keratin 14 expression, and the study suggests potential therapeutic targets while ensuring patient safety through ethical considerations.
